共 130 条
[1]
Bell S(2020)The future of cystic fibrosis care: a global perspective Lancet Respir Med 8 65-124
[2]
Mall M(2016)Cystic fibrosis Lancet 388 2519-2531
[3]
Gutierrez H(2015)Cystic fibrosis Nat Rev Dis Primers 1 15010-431
[4]
Macek M(2018)The burden of cystic fibrosis in the Medicaid population Clinicoecon Outcomes Res 10 423-2844
[5]
Madge S(2021)Healthcare resource utilization and costs among children with cystic fibrosis in the United States Pediatr Pulm 56 2833-1819
[6]
Davies J(2019)Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a single N Engl J Med 381 1809-1948
[7]
Elborn J(2019) allele Lancet 394 1940-825
[8]
Ratjen F(2021)Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the N Engl J Med 385 815-1532
[9]
Bell S(2021) mutation: a double-blind, randomised, phase 3 trial Am J Respir Crit Care Med 203 1522-67
[10]
Rowe S(2023)Triple therapy for cystic fibrosis Am J Respir Crit Care Med 208 59-78